Form 4: Arteris 10% Owner Bayview Legacy Reduces Stake

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., sold a total of 50,000 shares of common stock in pre-planned transactions.

Summary

• Bayview Legacy, LLC, identified as a 10% owner and director-related entity of Arteris, Inc. (AIP), disposed of 50,000 shares of common stock.
• The sales occurred on February 9, 2026, and February 10, 2026, under a Rule 10b5-1 trading plan adopted on March 5, 2025.
• On February 9, 2026, 47,244 shares were sold at a weighted average price of $15.2053, with prices ranging from $14.51 to $15.46.
• On February 10, 2026, an additional 2,756 shares were sold at a weighted average price of $15.0322, with prices ranging from $14.85 to $15.22.
• Following these transactions, Bayview Legacy, LLC beneficially owns 9,349,071 shares of Arteris, Inc. common stock.
• K. Charles Janac, manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over these shares and filed a separate Form 4 for the same transactions.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as slightly negative. While the 10b5-1 plan indicates a pre-scheduled transaction rather than a reaction to new information, the reduction in a significant insider's stake can still be interpreted as a lack of increasing conviction or a move for liquidity, which is not typically a strong positive signal for investors.

Positives

• The transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan, indicating the sales were not a reaction to recent negative company-specific news but rather a scheduled event.

Negatives

• A significant owner reducing their stake, even if pre-planned, can sometimes be interpreted by the market as a signal of reduced conviction or a need for liquidity, potentially creating downward pressure on sentiment.

Management Comments

• K. Charles Janac, as the manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.
• K. Charles Janac, in his individual capacity, separately filed a Form 4 reporting the same transaction due to his beneficial ownership through Bayview Legacy, LLC, which he controls.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those by significant owners like Bayview Legacy, LLC, are closely watched by investors as they can provide insights into management's perspective on the company's valuation and future prospects. While a 10b5-1 plan mitigates the immediate signaling effect, the reduction in overall insider ownership is still a data point for market participants.

Related Party Transactions

• The sale of common stock by Bayview Legacy, LLC, a 10% owner and entity controlled by K. Charles Janac (who is also a director), constitutes a related party transaction.

Stakeholder Impact

• Shareholders may interpret the insider sale as a signal regarding the company's future prospects or valuation, potentially influencing their investment decisions.
• The transparency provided by the 10b5-1 plan offers clarity to stakeholders that the transaction was pre-scheduled.

Key Dates

Recommendation

A single Form 4 detailing a pre-planned insider sale, even by a significant owner, typically does not warrant a change in fundamental investment recommendation. While the sale reduces insider ownership, the 10b5-1 plan suggests it's not based on new, adverse information. Investors should 'hold' their positions and monitor for broader company performance or further insider activity before making significant changes.

Keywords

Arteris, AIP, Bayview Legacy, K. Charles Janac, Insider Sale, Form 4, 10b5-1 Plan, Stock Transaction, Beneficial Ownership